Search

Glaukos Corp

Fermé

SecteurSoins de santé

160.24 -1.01

Résumé

Variation du prix de l'action

24h

Actuel

Min

159.61

Max

163.82

Chiffres clés

By Trading Economics

Revenu

1.4M

-18M

Ventes

35M

186M

BPA

-0.14

Marge bénéficiaire

-9.901

Employés

1,094

EBITDA

-1.6M

-6.9M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+19.84% upside

Dividendes

By Acuity

Prochains Résultats

28 oct. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.2B

10B

Ouverture précédente

161.25

Clôture précédente

160.24

Sentiment de l'Actualité

By Acuity

50%

50%

111 / 339 Classement par Healthcare

Glaukos Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

21 sept. 2026, 20:06 UTC

Glaukos Corp's shares are declining, remaining below their 20-day moving average and near the lower end of their one-month range despite an earlier session recovery.

18 sept. 2026, 20:02 UTC

Glaukos Corp is advancing during market hours on Friday, continuing its upward trend since Thursday's close, despite lower trading compared to earlier sessions.

17 sept. 2026, 19:36 UTC

Glaukos Corp shares fell sharply, currently at their lowest point of the day and significantly below the 20-day moving average.

16 sept. 2026, 19:03 UTC

Glaukos Corp shares fell sharply, reversing a trend of higher daily closes, amid unusually high market volume on Wednesday.

14 sept. 2026, 19:16 UTC

Glaukos Corp shares are higher today, despite no specific news, following three consecutive sessions of declines. The stock remains below its 20-day moving average.

11 sept. 2026, 20:08 UTC

Glaukos Corp shares are lower today, continuing a decline over the past four sessions and trading below the 20-day moving average.

10 sept. 2026, 20:03 UTC

Glaukos Corp shares are lower today, breaking a trend of higher closes. The stock is trading with unusually high volume amid no specific news.

8 sept. 2026, 20:07 UTC

Glaukos Corp shares are higher today, recovering from an early dip amid speculation of a potential interest rate hike following a strong jobs report.

1 sept. 2026, 19:31 UTC

Glaukos Corp. shares are lower today amid broader market volatility and rising U.S. Treasury yields, continuing a three-session decline.

31 août 2026, 20:07 UTC

Glaukos Corp shares are lower amid broader market concerns over inflation and potential Fed rate hikes. Earlier, the stock rebounded from a session low.

28 août 2026, 20:07 UTC

Glaukos Corp shares are lower during Friday's session amid rising U.S. Treasury yields and broader market trends, with no specific company news identified.

27 août 2026, 20:07 UTC

Glaukos Corp. shares are higher amid broader market trends. A decline in initial jobless claims may support a positive outlook for health care stocks.

25 août 2026, 20:07 UTC

Glaukos Corp shares are lower today amid broader market declines, despite remaining above their 20-day moving average and near the top of their one-month range.

21 août 2026, 19:56 UTC

Glaukos Corp's shares are higher today, reflecting a cumulative gain since Thursday. The stock remains near the upper end of its one-month range.

20 août 2026, 20:06 UTC

Glaukos Corp. shares are lower today, reflecting a decline from Wednesday's close. The stock earlier pulled back after reaching a session high.

19 août 2026, 20:06 UTC

News

Glaukos Corp will present at the Wells Fargo Healthcare Conference on September 9, 2026, as shares gain during Wednesday's trading session.

14 août 2026, 19:46 UTC

Glaukos Corp. shares are lower today, reaching a session low amid broader market declines following a surprise drop in U.S. retail sales for July.

13 août 2026, 19:22 UTC

Glaukos Corp. shares are higher today amid unusually high trading volume. The stock remains significantly above its 20-day moving average.

12 août 2026, 19:16 UTC

Glaukos Corp shares are higher today, supported by overall strength in U.S. stocks and positive quarterly results from AI sector companies.

10 août 2026, 20:06 UTC

Glaukos Corp shares are higher today, following a broader market trend since Friday. Earlier, the stock reached a session high before pulling back.

7 août 2026, 20:02 UTC

Glaukos Corp shares are rising in Friday's session, supported by unusually high trading volume and a steady upward trend since Thursday's close.

4 août 2026, 19:36 UTC

Glaukos Corp shares are lower today, impacted by declines in the Health Care Equipment sub-sector. The stock pulled back after reaching an earlier high.

3 août 2026, 20:06 UTC

Glaukos Corp shares are higher amid positive market sentiment, with the S&P 500 and Nasdaq 100 also gaining. The stock remains above its 20-day moving average.

31 juil. 2026, 19:45 UTC

News

Glaukos shares are lower today despite H.C. Wainwright raising the price target to $195 from $168. Trading volume has been unusually high.

30 juil. 2026, 21:31 UTC

News

Glaukos Corp shares are lower in after-market trading, tracking declines in the Health Care Equipment sector. UBS raised its price target to $172.

29 juil. 2026, 21:22 UTC

Social Media
News

Glaukos Corp reported record net sales of $185.6 million in Q2 2026, raising its full-year revenue guidance to $680 million to $700 million. Shares are higher in after-market trading.

28 juil. 2026, 17:46 UTC

News

Glaukos Corp shares are lower after UBS initiated coverage with a Neutral rating, overshadowing Stifel's Buy rating and $175 price target.

27 juil. 2026, 19:16 UTC

Glaukos Corp shares are lower today, despite an initial gain. Broader market trends are affected by a significant drop in oil prices.

24 juil. 2026, 19:56 UTC

Glaukos Corp. shares are trading higher today, maintaining a cumulative gain since Thursday and remaining above their 20-day moving average.

21 juil. 2026, 17:41 UTC

Glaukos Corp shares are lower today amid a decline in the Health Care Equipment sub-sector, reversing the recent trend of higher daily closes.

Comparaison

Variation de prix

Glaukos Corp prévision

Objectif de Prix

By TipRanks

19.84% hausse

Prévisions sur 12 Mois

Moyen 193.583 USD  19.84%

Haut 225 USD

Bas 165 USD

Basé sur 13 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

13 ratings

12

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

111 / 339Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.